Never miss an update from Yeda
Create your free account to connect with Yeda and thousands of other innovative organizations and professionals worldwide
Implantable or insertable medical devices must be made of materials with unique properties in addition to biocompatibility to address potential damage from the physiological environment and to maintain their effectiveness over time. For instance, urethral medical devices (e.g., catheters) are damaged by the encrustation of minerals from the urine, which results in their frequent replacement. Various medical applications suffer from excessive friction, severely compromising their function leading to prolonged treatments. Prof. Tenne and his team developed a novel method for coating medical devices using inorganic fullerene-like nanoparticles to increase their lubricity and prevent encrustation. This coating is applicable for various devices such as stents, catheters, dialysis tubes, cannulas, and sutures.
The Need
Implantable or insertable medical devices must be biocompatible and possess specific mechanical properties depending on their designated use. In addition, they should also be resistant to potential damage by the physiological environment to ensure their long-lasting effectiveness. In the case of urethral medical devices (e.g., catheters), their exposure to calcium and phosphate ions from the urine results in the formation of crystals on the biomaterial surface, a process known as encrustation. Encrustation may cause infections and harm the medical device's functionality, resulting in its frequent replacement, which is inconvenient to the patient and costly. Also, excessive friction severely compromises the insertion and retrieval of medical devices from narrow constrictions in the body, and leads to pain and morbidity of the paitent. In this context, one of the field's major goals is to search for new products that would generate less friction during insertion and retrieval of catheters, endoscopes and laparoscopes through narrow natural and purposely cut constrictions in the human body. Additionally, coating of endodontic files (EFs) used for root canal treatment can benefit from this technology as well. Finding a way to reduce file breakage during root canal treatment would greatly influence the costs of treatment and the prognosis of treated teeth stages and conditions. Therefore, there is a need for an efficient, general coating method to increase lubricity, thus preventing encrustation and reducing friction.
The Solution
Prof. Reshef Tenne and his team developed a novel method for coating medical devices to reduce friction and increase lubricity using inorganic fullerene-like nanoparticles (IF?WS2, IF-MoS2) 1,2
Technology Essence
Fullerene-like nanoparticles (i.e., IF-WS2, IF-MoS2) are deposited on top of medical devices and change their surface properties dramatically. These nanoparticles produce coating films with a relatively small tendency to agglomerate. This architecture, together with the low affinity of the nanoparticles towards the environment (due to closed caged moieties which lack dandling bonds), results in their superior lubricity.
Applications and Advantages
Applications
Advantages
Non-toxic
Cheap
References
1. Adini AR, Feldman Y, Cohen SR, et al. Alleviating fatigue and failure of NiTi endodontic files by a coating
containing inorganic fullerene-like WS 2 nanoparticles. J Mater Res. 2011;26(10):1234-1242. doi:10.1557/jmr.2011.52 [1]
2. Goldbart O, Yoffe A, Cohen SR, et al. New Deposition Technique for Metal Films Containing Inorganic FullereneLike (IF) Nanoparticles. ChemPhysChem. 2013;14(10):2125-2131. doi:10.1002/cphc.201201003 [2]
Yeda ("Knowledge" in Hebrew) Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science (WIS) and is the second company of its kind established in the world.
WIS is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel and Founder of the Institute.
Yeda initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by WIS scientists. Yeda holds an exclusive agreement with WIS to market and commercialize its intellectual property and generate income to support further research and education.
Since 1959 Yeda has generated the highest income per researcher compared to any other TTO worldwide. Weizmann has generated a number of groundbreaking therapies, such as Copaxone, Rebif, Tookad, Erbitux, Vectibix, Protrazza, Humira, and recently the CAR-T cancer therapy Yescarta.
Yeda performs the following activities:
◣ Identifies and assesses research projects with commercial potential.
◣ Protects the intellectual property of WIS and its scientists.
◣ Licenses WIS' inventions and technologies to industry.
◣ Establishes new Startup companies based in WIS Intellectual Property
◣ Channels funding from industry to research projects.
Our portfolio covers a broad spectrum of the natural sciences, including:
◣ Agriculture and Plant Genetics, including Bio-fuels
◣ Chemistry and Nanotechnology
◣ Environmental Sciences and Solar Energy
◣ Mathematics and Computer Science
◣ Medical Devices
◣ Pharmaceuticals and Diagnostics
◣ Physics and Electro-Optics
◣ Research Tools
Create your free account to connect with Yeda and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Yeda
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support